Traditional Chinese medicine composition for preventing fracture postoperative lower limb deep venous thrombosis, and preparation method thereof
A technology of deep vein thrombosis and composition, which is applied in the field of traditional Chinese medicine composition and its preparation for preventing deep vein thrombosis of lower extremities after fracture surgery, can solve the problems of high risk, bleeding adverse events, and high cost, and achieve the prevention of DVT, The effect of improving the stasis state and restoring the gasification function
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0031] A traditional Chinese medicine composition for preventing deep vein thrombosis of lower extremities after fracture operation, which is a medicament made of the following traditional Chinese medicine raw materials in weight ratio:
[0032] 15 parts of astragalus, 10 parts of angelica, 10 parts of cassia twig, 5 parts of chuanxiong, 5 parts of peach kernel, 5 parts of safflower, 3 parts of ground dragon powder, 3 parts of leech powder, and 3 parts of panax notoginseng.
Embodiment 2
[0034] A traditional Chinese medicine composition for preventing deep vein thrombosis of lower extremities after fracture operation, which is a medicament made of the following traditional Chinese medicine raw materials in weight ratio:
[0035] 45 parts of astragalus, 20 parts of angelica, 20 parts of cassia twig, 15 parts of Chuanxiong, 15 parts of peach kernel, 15 parts of safflower, 9 parts of earthworm powder, 9 parts of leech powder, and 9 parts of notoginseng.
Embodiment 3
[0037] Below, introduce a preferred embodiment of the present invention in conjunction with clinical data:
[0038] 1 Materials and methods
[0039] 1.1 General information 1860 patients with lower extremity fractures who were admitted to Xi'an Honghui Hospital from October 2016 to October 2019 were admitted for ultrasound examination of the veins of both lower extremities. The average age of all patients was 49.6 years; they were randomly divided into experimental group and control group. There was no statistically significant difference between the two groups in the incidence of DVT, age, sex, comorbidities and other general information at admission (P>0.05), and they were comparable.
[0040] 1.2 Method
[0041] Control group: low molecular weight heparin calcium 4100U, subcutaneous injection, once a day;
[0042] Experimental group: adopt Chinese medicine prescription treatment of the present invention: Astragalus 30g, Angelica 15g, Guizhi 15g, Rhizoma Chuanxiong 10g, p...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com